|
|
 |
|
Viewing report
|
|
 |
 |
Inverness Medical Innovations Inc - Competitor Report
Life Science Analytics, March 2008, Pages: 8
The Inverness Medical Innovations Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.
Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.
Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The Inverness Medical Innovations Inc Competitor report therefore delivers the latest and the most comprehensive intelligence available on the key companies active within Inverness Medical Innovations Incs markets.
Customers who bought this item also bought
Protherics PLC - Competitor Report
Neoforma Inc - Financial Report
Merger�and Acquisition�Agreements in Biopharma
Inverness Medical Innovations, Inc. and the U.S. In-Vitro Diagnostic Substance Manufacturing Industry
The Global Market for Point of Care Diagnostics - Major Players and Key Issues
Bigpharma Dealmaking Handbook 2007
Automated and Rapid Microbiological Tests - Global Strategic Business Report
Cardiovascular Biomarkers: Players, Products and Prospects (Volume III)
Medical Laser Systems - Global Strategic Business Report
Partnering�with Bigpharma: The Definitive Guide to Partnering Interests, Contacts & Agreements
Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market
Cancer, CNS & Cardiovascular Biomarkers: Players, Products and Prospects
|
 |
|
|